Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Oligometastatic Prostate Carcinoma · Prostate Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Principal Investigator (Carlos E. Vargas, M.D.)

Study leads

Carlos E. Vargas, M.D.
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Biochemically Recurrent Prostate Carcinoma · Oligometastatic Prostate Carcinoma · Recurrent Prostate Adenocarcinoma

Abroad (travel likely)RecruitingPHASE3

Scottsdale, United States · Albert Lea, United States

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Prostate Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Pittsburgh, United States · Seattle, United States

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

Localized Prostate Carcinoma · Oligometastatic Prostate Carcinoma · Stage I Prostate Cancer AJCC v8

Abroad (travel likely)Recruiting

Jacksonville, United States

Addressing Health Literacy With a Tailored Survivorship Care Plan

Localized Prostate Carcinoma · Oligometastatic Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8

Abroad (travel likely)Recruiting

Atlanta, United States · Atlanta, United States